68.26
price down icon1.50%   -1.04
after-market  Dopo l'orario di chiusura:  68.26 
loading

Dr. Reddy's Laboratories Ltd. ADR Borsa (RDY) Ultime notizie

India shares higher at close of trade; Nifty 50 up 0.92% - Investing.com South Africa

pulisher
Investing.com South Africa

India shares higher at close of trade; Nifty 50 up 0.51% - Investing.com South Africa

pulisher
Investing.com South Africa

MC Inside Edge: Mugul’s Capital play, action hots up in Dr Reddy’s, Voltas bulls cool it, Indigo... - Moneycontrol

pulisher
Moneycontrol

Asian Equities Traded in the US as American Depositary Receipts Begin Week Higher - MSN

pulisher
MSN

Is First Trust BICK Index Fund (BICK) a Hot ETF Right Now? - Yahoo News UK

pulisher
Yahoo News UK

Financial Firms Lead Asian Equities Traded in the US as American Depositary Receipts Lower in Monday Trading - MSN

pulisher
MSN

Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term

pulisher
Zacks Investment Research

Dr. Reddy's Ends Fiscal Year With Strong Growth and Solid Margin Improvement - Morningstar

pulisher
Morningstar

Dr. Reddy's (RDY) Q4 Earnings Top, North America Sales Grow

pulisher
Zacks Investment Research

Dr. Reddy's Ends Fiscal Year With Strong Growth and Solid Margin Improvement - Morningstar

pulisher
Morningstar

Dr. Reddy's Labs ADR earnings beat by $0.04, revenue topped estimates - Investing.com India

pulisher
Investing.com India

Dr. Reddy's stock target reduced on weak earnings outlook - Investing.com India

pulisher
Investing.com India

BP ADR earnings missed by $0.04, revenue fell short of estimates - Investing.com India

pulisher
Investing.com India

Dr Reddy's Laboratories clocks 36 pc surge in Q4 net profit - Investing.com India

pulisher
Investing.com India

India shares lower at close of trade; Nifty 50 down 0.76% - Investing.com India

pulisher
Investing.com India

Zacks Industry Outlook Highlights Teva, Dr. Reddy's and Viatris

pulisher
Zacks Investment Research

Dr. Reddy's launches condition management programme DailyBloom IBS - Business Standard

pulisher
Business Standard

3 Generic Drug Stocks to Watch Amid Challenging Market Prospects

pulisher
Zacks Investment Research

Stocks to Watch: TCS, Wipro, Vi, TaMo, HUL, CAMS, Dr Reddy's, Adani Total Gas | Mint - Mint

pulisher
Mint

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

pulisher
Zacks Investment Research

Dr Reddy's to market Bayer's second brand of heart failure drug in India - Business Standard

pulisher
Business Standard

Tata Steel, Dr Reddy's Labs, Axis Bank: Trading strategies for these buzzing stocks - Business Today

pulisher
Business Today

Dr. Reddy's Laboratories Stocks Updates: Dr. Reddy's Laboratories Sees 1.44% Price Surge, Closes at Rs 6... - Economic Times

pulisher
Economic Times

Dr. Reddy's Laboratories Stocks Updates: Dr. Reddy's Laboratories Stock Price Drops by 1.18% Today, SMA7... - Economic Times

pulisher
Economic Times

Dr Reddys Laboratories enters into license agreement with Pharmazz - Business Standard

pulisher
Business Standard

Here's Why Doctor Reddy's (RDY) is a Strong Value Stock

pulisher
Zacks Investment Research

Market Trading Guide: Tech Mahindra, Dr Reddy's Laboratories among 4 stock recommendations for Wednesday ... - The Economic Times

pulisher
The Economic Times

Dr. Reddy's Laboratories Share Price Today Live Updates: Dr. Reddy's Laboratories Sees 0.81% Increase in... - Economic Times

pulisher
Economic Times

News Analysis | As ECI reveals electoral bonds data, BJP tops beneficiary list; biggest donor is little-known Future Gaming - Frontline

pulisher
Frontline

Electoral Bonds data: Megha Engineering & Infrastructure, Dr Reddy's among top buyers - NewsMeter

pulisher
NewsMeter

Why Dr. Reddy's Lab Shares Crashed Near End Of Trading On Friday - Investing.com India

pulisher
Investing.com India

Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term

pulisher
Zacks Investment Research

Here's Why Doctor Reddy's (RDY) is a Strong Momentum Stock

pulisher
Zacks Investment Research

Why Doctor Reddy's (RDY) is a Top Growth Stock for the Long-Term

pulisher
Zacks Investment Research

Buzzing Stocks: Dr Reddy’s, Tejas Network, LTI Mindtree, Brigade Enterprises and others - Moneycontrol

pulisher
Moneycontrol

BPCL Lead Nifty 50 Gainers As Markets End In Green After Rough Day - Investing.com India

pulisher
Investing.com India

Stock recommendations by analyst for February 13: Wipro, Kalyan Jewellers and Dr Reddy's - Business Today

pulisher
Business Today

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

pulisher
Zacks Investment Research

Why Doctor Reddy's (RDY) is a Top Momentum Stock for the Long-Term

pulisher
Zacks Investment Research

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

pulisher
Zacks Investment Research

Dr. Reddy's (RDY) Q3 Earnings and Revenues Surpass Estimates

pulisher
Zacks Investment Research

Share Market Highlights 31 January 2024: Sensex climbs 612 pts; Nifty settles above 21700; Dr Reddy's, Eicher Motors ... - BusinessLine

pulisher
BusinessLine

Zacks Industry Outlook Highlights Amphastar, Teva and Dr. Reddy's

pulisher
Zacks Investment Research

3 Generic Drug Stocks to Watch Amid Improving Market Prospects

pulisher
Zacks Investment Research

RDY Stock Quote Price and Forecast - CNN

pulisher
CNN

India shares higher at close of trade; Nifty 50 up 0.13% - Investing.com India

pulisher
Investing.com India

How to Identify Stock Market Winners Early in 2024

pulisher
Zacks Investment Research

India shares higher at close of trade; Nifty 50 up 0.57% - Investing.com India

pulisher
Investing.com India

Dr Reddy's Laboratories sheds around 7% as USFDA issues 3 observations for firm | Mint - Mint

pulisher
Mint

Here's Why Doctor Reddy's (RDY) is a Strong Momentum Stock

pulisher
Zacks Investment Research
$55.37
price up icon 0.22%
$10.98
price down icon 0.36%
$17.19
price up icon 1.24%
$142.29
price up icon 0.27%
$65.00
price down icon 2.30%
Capitalizzazione:     |  Volume (24 ore):